Ibogaine Abstracts on PubMed

18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-MC, a novel iboga alkaloid congener, is being developed as a potential treatment for multiple forms of drug abuse. Like ibogaine (40 mg/kg), 18-MC …

Continue reading

Uncovering Ibogaine

the Deborah Mash Interview with Paul DeRienzo Dr. Deborah Mash is a faculty member in the Department of Neurology of the University of Miami, School of Medicine with a secondary appointment in Cellular Molecular Pharmacology. Dr. Mash’s area of expertise is called Neuropharmacology and Neuroscience and her doctoral dissertation was …

Continue reading

Addiction Treatment Strives for Legitimacy

by Brian Vastag Journal of the American Medical Association Vol. 288 No. 24, pp. 3096-3101, December 25, 2002 © 2002 American Medical Association. All rights reserved. Tabernanthe iboga, the West African source of ibogaine, used by some to treat addiction. New York — Some drugs are made in laboratories. Others, …

Continue reading

Ibogaine: A Novel Anti-Addictive Compound…

Ibogaine: A Novel Anti-Addictive Compound A Comprehensive Literature Review By: Jonathan Freedlander Advisor: Carlo DiClemente, Ph.D. University of Maryland, Baltimore County Introduction and History Ibogaine is a naturally occurring indole alkaloid, found in a variety of African shrubs of the Tabernanthe genus (Obach, Pablo, and Mash, 1998). The root of …

Continue reading